(MENAFN- GetNews) The factors that drive the dengue vaccine market are rising prevalence of dengue, increasing novel drug treatment, convenience of purchase, affordability of vaccine, high adoption and acceptance in developing markets, and innovations and developments in vaccine. Dengue Vaccine Market Size and Growth Rate:
Dengue Vaccine Market was valued USD 0.22 billion in 2016 and is expected to reach USD 1.15 billion by 2024 at a CAGR of 17% over the forecast period.
Browse 280 pages of the detailed report and TOC @ https://www.researchcosmos.com/reports/global-dengue-vaccine-market-analysis-and-forecast-2016-2024-industry-growth-opportunities/5935471
Dengue Vaccine Market Growth Drivers and Restraints:
The factors that drive the dengue vaccine market are rising prevalence of dengue, increasing novel drug treatment, convenience of purchase, affordability of vaccine, high adoption and acceptance in developing markets, and innovations and developments in vaccine. The market also faces some limitations, such as the fierce competition among existing players to develop a new vaccine, the high risk of side effects of the vaccine, the complications and severity associated with taking incorrect medications due to misdiagnosis, population rural development and underdeveloped economies.
Geographical Presence of Dengue Vaccine Market:
Geographically, the dengue vaccine market has been segmented into five main regions: North America, Europe, Asia-Pacific, Latin America and Middle East and Africa. North America is the largest market for dengue vaccine in terms of income, followed by Europe. The United States has the largest market share in the region. Asia Pacific and Latin America are emerging markets that are expected to experience strong growth during the forecast period from 2017 to 2025. The strong growth in these regions is attributed to the rising incidence of dengue, the growth of the health care sector and the increase of public investment to expand the health care infrastructure. The dengue vaccine market in countries such as China, India and Brazil, is expected to grow at a high growth rate during the forecast period due to increased public awareness of the disease and its treatment.
Avail Sample of the report for more information @ https://www.researchcosmos.com/request/global-dengue-vaccine-market-analysis-and-forecast-2016-2024-industry-growth-opportunities/5935471
Key Players of Dengue Vaccine Market:
Some of the leading market players of Dengue Vaccine Market are Sanofi Pasteur, Biological E. Limited, Merck & Co., Glaxosmithkline, Pfizer, Panacea Biotech Ltd., Vabiotech, Butantan Institute and others.
Dengue Vaccine Market Segmentation:
By Technology:
Live attenuated vaccine Chimeric Live attenuated vaccine Subunit vaccine Inactivated vaccine Nucleic acid based vaccine By End Users:
Hospital Diagnostic Labs NGO's Government Institutes By Region:
North America South America Europe Asia Pacific Middle East and Africa Make an Inquiry before buying @ https://www.researchcosmos.com/inquire/global-dengue-vaccine-market-analysis-and-forecast-2016-2024-industry-growth-opportunities/5935471
Media Contact
Company Name: Research Cosmos
Contact Person: Kevin Stewart
Email: Send Email
Phone: 1-888-709-8757
Address:4390 U.S 1, Suite 211
City: Princeton
State: New Jersey
Country: United States
Website: https://www.researchcosmos.com/reports/global-dengue-vaccine-market-analysis-and-forecast-2016-2024-industry-growth-opportunities/5935471
MENAFN1202201900703268ID1098107107
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.